title: Should an angiotensin-converting enzyme inhibitor be given at the time of reperfusion therapy in acute myocardial infarction?
authors.forename: Craig Steven
authors.initials: CS
authors.lastname: McLachlan
authors.forename: Ryan
authors.initials: R
authors.lastname: Ocsan
authors.forename: Brett
authors.initials: B
authors.lastname: Hambly
authors.forename: Reida
authors.initials: R
authors.lastname: El Oakley
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D001026:Coronary Artery Bypass / Q000379:methods / Q000401:mortality; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000401:mortality* / Q000628:therapy*; D015425:Myocardial Reperfusion / Q000379:methods / Q000401:mortality*; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D016019:Survival Analysis
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors